Vitamin Shoppe (VSI) Misses Q2 EPS by 16c, Miss on Revenues

Vitamin Shoppe (NYSE: VSI) reported Q2 EPS of $0.23, $0.16 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $304.8 million versus the consensus estimate of $314.74 million.

Second Quarter 2017 Highlights:

• Total Comparable Sales Down 8.3%
  • Sports-related categories primary drivers of decline
• GAAP loss per share of $6.73
  • Records impairment charges of $168.1 million
• Company Launches Sales Driving Initiatives to Improve Competitiveness
  • New pricing strategy
  • SPARK™ Auto-Delivery subscriptions
• Supply Chain and Manufacturing Restructuring to Further Reduce Costs
  • Rationalization of supply chain network – to close New Jersey distribution center in addition to continued restructuring at Nutri-Force

2017 Outlook

Given the unprecedented level of volatility in the market and the potential increase in variability of the Company\'s results due to the number of initiatives being launched in the back half of the year, the Company has reset its 2017 outlook and is modifying its approach to guidance. The Company is providing guidance around the key levers that drive the business instead of providing specific EPS guidance.

• The Company expects full year comparable sales decline rate of negative mid-single digits.
• Reported full year gross margin rate of 30.2% to 30.7%. This includes charges associated with the Nutri-Force restructuring and North Bergen closure this year. Excluding these charges, full year gross margins of 31.3% to 31.8% (Refer to Table 5 at the end of this press release.).
• Full year SG&A expense of $342 million to $347 million including charges associated with the Nutri-Force restructuring. Excluding these charges, full year SG&A expense of $335 million to $340 million (Refer to Table 5 at the end of this press release.).
• Full year capital expenditures of $45 million, including build out of distribution center in Arizona, IT investments, approximately 15 new stores and 10-15 brand defining store transformations.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c